Saïdal’s PGD, Wassim Kouidri, claimed that the new business model adopted by the state-owned group specializing in the manufacture of pharmaceutical products will reduce the drug import bill by $1.1 billion in 2026. Read more…
Towards pharmaceutical self-sufficiency
Algeria has taken a crucial step in its strategy of pharmaceutical self-sufficiency, with the official inauguration of the second private bioequivalence center launched by Clinica Group. Read more…